Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban

Conditions

• Anticoagulant Reversal
• Reversal of Edoxaban Induced Anticoagulation

Interventions

• DRUG: PER977, Placebo

Sponsor

Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.